Cyclerion Therapeutics (CYCN) Merges With Korsana Biosciences to Advance Alzheimer's Pipeline [Yahoo! Finance]
Cyclerion Therapeutics, Inc. (CYCN)
Company Research
Source: Yahoo! Finance
Cyclerion Therapeutics Inc. (NASDAQ: CYCN ) is one of the unstoppable stocks that could double your money. On April 1, Cyclerion and Korsana Biosciences entered into a definitive merger agreement to form a combined entity operating under the name Korsana Biosciences, trading under the ticker ‘KRSA'. The merger aims to advance Korsana's neurodegenerative disease pipeline, headlined by KRSA-028, a next-gen antibody targeting amyloid beta for Alzheimer's disease. This lead program uses the proprietary THETA platform, which is designed to improve brain delivery and safety while offering the convenience of subcutaneous administration. In conjunction with the merger, Korsana secured $380 million in private financing from a syndicate of leading healthcare investors, including Fairmount and Venrock Healthcare Capital Partners. This capital is expected to fund operations into 2029, providing the necessary runway to reach critical clinical milestones. Key upcoming data readouts include Pha
Show less
Read more
Impact Snapshot
Event Time:
CYCN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYCN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYCN alerts
High impacting Cyclerion Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CYCN
News
- Are UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders?PR Newswire
- BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cyclerion Therapeutics, Inc. (Nasdaq – CYCN), National Storage Affiliates (NYSE - NSA), Urgent.ly, Inc. (OTC Markets - ULYX), UniFirst Corporation (NYSE - UNF)GlobeNewswire
- BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cyclerion Therapeutics, Inc. (Nasdaq – CYCN), National Storage Affiliates (NYSE - NSA), Urgent.ly, Inc. (OTC Markets - ULYX), UniFirst Corporation (NYSE - UNF)GlobeNewswire
- SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN)PR Newswire
- CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its ShareholdersBusiness Wire
CYCN
Sec Filings
- 4/20/26 - Form S-4
- 4/1/26 - Form 425
- 4/1/26 - Form 8-K
- CYCN's page on the SEC website